Global Proteomics Market Size, Share, and Growth & Trends Analysis By Component (Reagents- Microarray, X Ray Crystallography, Spectrometry, Chromatography, Electrophoresis, Immunoassay, Protein Fractionation Reagents, Instruments- Microarray, Spectrometry, Chromatography, Electrophoresis, Surface Plasmon Resonance, X Ray Crystallography, Protein Fractionation Reagents, Services) By Application (Drug Discovery, Disease Diagnosis, Others) By Region (North America, Asia Pacific, Europe, Middle East & Africa, South America): Regional Outlook, Growth Potential and Segments Forecast 2024-2031

Loading...

Budget constraints? Get in touch with us for special pricing

Buying Options

Original price was: $6,000.00.Current price is: $5,100.00.
Original price was: $5,000.00.Current price is: $4,500.00.
Original price was: $4,000.00.Current price is: $3,800.00.
Loading...

Description

The Global Proteomics Market size was USD 161.9 billion in 2023 and is projected to reach USD 310.4 billion by 2031, with a CAGR of 14.2 % during the forecast period. 

Global Proteomics Market: Overview

The Proteomics market has seen significant advancements driven by technological innovations and expanding applications. Key developments include enhanced mass spectrometry techniques like Bruker Corporation’s timsTOF HT with its 4th-generation TIMS XR cell and high-resolution digitizer, enabling broader peptide coverage and accurate quantitation in 4D proteomics. Single-molecule protein sequencing technologies, such as nanopores and protein degradation methods, aim to measure peptides at single-cell levels, while spatial proteomics maps protein distributions within tissues, elucidating cellular functions and disease mechanisms. Portable proteomics platforms have democratized protein analysis in clinical and remote settings. Integrating proteomic data with genomics and transcriptomics enhances drug target validation and biomarker discovery, driving adoption in pharmaceuticals. Optimizing protein production ensures biopharmaceutical quality, while microbial proteomics explores host-microbe interactions for health and agricultural applications. These advancements collectively propel Proteomics forward, enabling precise protein analysis and deeper insights into biological processes and diseases, shaping future innovations across healthcare, biopharmaceuticals, and environmental sciences.

Global Proteomics Market: Covid-19 Impact

The COVID-19 pandemic has significantly impacted the proteomics market, driving increased research and development. Proteomics technologies, like mass spectrometry and protein microarrays, have seen heightened demand for studying viral proteins and host responses. This surge has accelerated innovation in diagnostic tools and therapeutic development, focusing on identifying biomarkers and drug targets. As a result, the proteomics market has experienced rapid growth and diversification in applications related to infectious diseases like COVID-19.

Global Proteomics Market: Growth Drivers

  • Advancements in Technology:

Technological advancements in mass spectrometry, chromatography, and bioinformatics have significantly enhanced the sensitivity, speed, and accuracy of proteomic analysis. This has led to increased adoption in pharmaceutical and biotechnology industries for drug discovery and development, thereby driving market growth.

  • Increasing Research Funding:

Government and private investments in research and development activities related to proteomics have risen. This funding supports basic research, biomarker discovery, and clinical proteomics applications, fostering market expansion.

  • Rising Demand for Personalized Medicine:

Proteomics plays a crucial role in identifying biomarkers for disease diagnosis, prognosis, and therapeutic response prediction. As personalized medicine gains prominence, there’s growing demand for proteomic technologies to tailor treatments based on individual patient profiles, driving market growth.

Global Proteomics Market: Restraining Factors

  • High Cost of Instruments and Services:

Proteomics instrumentation and services can be expensive, limiting adoption among smaller research laboratories and institutions with budget constraints. This cost factor poses a barrier to market growth, particularly in developing regions.

  • Complexity in Data Analysis:

The large volume and complexity of proteomic data require sophisticated bioinformatics tools and expertise for accurate interpretation. The complexity of data analysis can slow down research workflows and hinder the adoption of proteomic technologies, serving as a restraint.

Global Proteomics Market:  Opportunity Factors

  • Expansion in Emerging Markets:

There is significant untapped potential for proteomics technologies in emerging markets due to increasing healthcare expenditure, rising research capabilities, and growing awareness about personalized medicine. This presents opportunities for market expansion and penetration.

  • Application in Clinical Diagnostics:

Proteomic technologies hold promise for improving diagnostic accuracy and precision in clinical settings. As biomarker discovery progresses, there are opportunities to develop diagnostic assays for various diseases, enhancing the role of proteomics in clinical diagnostics. 

Global Proteomics Market: Challenges

  • Standardization and Quality Control:

Ensuring consistency and reliability across proteomic experiments remains a challenge. Standardization of protocols, quality control measures, and reproducibility of results are critical issues that need to be addressed to enhance the credibility and widespread adoption of proteomics technologies.

  • Ethical and Legal Considerations:

The use of proteomic data, especially in clinical and personalized medicine applications, raises ethical concerns regarding patient privacy, consent, and data ownership. Addressing these ethical and legal considerations is essential to foster trust among stakeholders and support sustainable growth in the proteomics market.

Global Proteomics Market: Segmentation

Based on Component: The market is segmented into Reagents- Microarray, X Ray Crystallography, Spectrometry, Chromatography, Electrophoresis, Immunoassay, Protein Fractionation Reagents, Instruments- Microarray, Spectrometry, Chromatography, Electrophoresis, Surface Plasmon Resonance, X Ray Crystallography, Protein Fractionation Reagents, Services.

Based on Application: The market is segmented into Drug Discovery, Disease Diagnosis, Others.

Global Proteomics Market: Regional Insights

  • North America:

North America’s proteomics market is rapidly expanding, driven by technology breakthroughs like as mass spectrometry and increased demand for proteomics solutions in precision medicine, drug discovery, and disease diagnostics. Recent advances have highlighted the creation of innovative businesses like as Alamar Biosciences, Pixelgen, and PreOmics, who are receiving significant funding to improve proteomics technologies, making them faster, more cost-effective, and more informative. Established companies such as Thermo Fisher, Bruker, and Agilent are actively collaborating with these startups, investing in partnerships to strengthen their own proteomics capabilities. This dynamic landscape highlights considerable growth, investment, and consolidation in the North American proteomics sector, establishing it as a critical tool for furthering precision medicine, drug discovery, and biological research.

  • Asia Pacific:

The Asia Pacific proteomics market is experiencing significant growth driven by advancements in proteomic technologies, increasing research activities in drug discovery and development, and rising investments in healthcare infrastructure. Countries like China, Japan, and India are pivotal in this growth, with expanding biotechnology and pharmaceutical sectors. The region benefits from a growing demand for personalized medicine and biomarker discovery, which fuels the adoption of proteomics to understand disease mechanisms and therapeutic targets. Key players in the market are investing in innovative solutions for protein analysis, including mass spectrometry and chromatography, enhancing the region’s capabilities in studying complex biological systems. Regulatory support and collaborations between academic institutions and industry players further accelerate market expansion. Challenges such as high costs associated with advanced proteomics tools and data analysis complexity are being addressed through technological advancements and strategic partnerships, fostering a robust and evolving proteomics landscape in the Asia Pacific region.

Global Proteomics Market: Competitive Landscape

Agilent Technologies Inc., Waters Corporation, Bruker Corporation, Merck KGaA, Perkin Elmer Inc, Bio-Rad Laboratories Inc, Li-Cor Inc, Thermo Fisher Scientific Inc., Horiba Ltd., Danaher Corporation.

Global Proteomics Market: Recent Developments

  • June 2024: Bruker Launches Ultimate Sensitivity timsTOF Ultra 2 to Enable New Research Paradigms in Single-Cell and Subcellular Proteomics.
  • June 2024: Bio-Rad Laboratories, Inc. a global leader in life science research and clinical diagnostics products, announced the launch of Celselect Slides 2.0 to enhance rare cell and circulating tumor cell (CTC) capture.

Table of Content

CHAPTER 1: EXECUTIVE SUMMARY
1.1. Summary
CHAPTER 2: RESEARCH METHODOLOGY
2.1. Research Process
2.2. Primary Research
2.3. Secondary Research
2.4. Market Size Estimation
2.5. Research Methodology
2.6. Analyst Tools/Models/Techniques
2.6.1. Notations
2.7. Market Scope & Segmentation
2.8. Currency & Pricing Considered
CHAPTER 3: MARKET TRENDS
3.1. Introduction
3.2. Drivers
3.2.1. Rising Demand for Personalized Medicine
3.3. Restraints
3.3.1. High Cost of Instruments and Services
3.4. Opportunities
3.4.1. Expansion in Emerging Markets
3.5. Challenges
3.5.1. Standardization and Quality Control
3.6. Investment Feasibility Analysis
3.7. Latest Trends
CHAPTER 4: MARKET ASSESSMENT
4.1. Porters Five Forces Analysis
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitute
4.1.5. Intensity of Competitive Rivalry
4.2. Value Chain Analysis
4.3. Market Share Analysis
4.4. Impact of Key Regulations on the Market
4.5. SWOT Analysis
4.6. PESTEL Analysis
4.7. Patent Analysis
4.7.1. BY COMPONENT
4.7.2. BY APPLICATION
4.8. Roadmap Development
4.9. Market Lineage Outlook
4.9.1. Parent Market Outlook
4.9.2. Ancillary Market Outlook
CHAPTER 5: IMPACT OF RECESSION ON THE MARKET
5.1. Introduction
5.1.1. Short Term Impact
5.1.2. Long Term Impact
CHAPTER 6: GLOBAL PROTEOMICS MARKET, BY COMPONENT
6.1. Introduction
6.1.1. Market Size & Forecast
6.1.2. Global Proteomics Market Share, BY COMPONENT -2023 and 2031 (%)
6.2. MICROARRAY
6.2.1. Key market Trends, Growth Factors, and Opportunities
6.2.2. Market Size and Forecast, by Regions
6.3. X RAY CRYSTALLOGRAPHY
6.3.1. Key market Trends, Growth Factors, and Opportunities
6.3.2. Market Size and Forecast, by Regions
6.4. SPECTROMETRY
6.4.1. Key market Trends, Growth Factors, and Opportunities
6.4.2. Market Size and Forecast, by Regions
6.5. CHROMATOGRAPHY
6.5.1. Key market Trends, Growth Factors, and Opportunities
6.5.2. Market Size and Forecast, by Regions
6.6. ELECTROPHORESIS
6.6.1. Key market Trends, Growth Factors, and Opportunities
6.6.2. Market Size and Forecast, by Regions
6.7. IMMUNOASSAY
6.7.1. Key market Trends, Growth Factors, and Opportunities
6.7.2. Market Size and Forecast, by Regions
6.8. SERVICES
6.8.1. Key market Trends, Growth Factors, and Opportunities
6.8.2. Market Size and Forecast, by Regions

CHAPTER 7: GLOBAL PROTEOMICS MARKET, BY APPLICATION
7.1. Introduction
7.1.1. Market Size & Forecast
7.1.2. Global Proteomics Market Share, BY APPLICATION -2023 and 2031 (%)
7.2. DRUG DISCOVERY
7.2.1. Key market Trends, Growth Factors, and Opportunities
7.2.2. Market Size and Forecast, by Regions
7.3. DISEASE DIAGNOSIS
7.3.1. Key market Trends, Growth Factors, and Opportunities
7.3.2. Market Size and Forecast, by Regions
7.4. OTHERS
7.4.1. Key market Trends, Growth Factors, and Opportunities
7.4.2. Market Size and Forecast, by Regions
CHAPTER 8: NORTH AMERICA MARKET ANALYSIS
8.1. Introduction
8.2. Proteomics Market by Country
8.3. North America Proteomics Market by Country, USD Million 2019-2031
8.3.1. Market Size & Forecast, BY COMPONENT
8.3.2. Market Size & Forecast, BY APPLICATION
8.4. U.S.
8.4.1. Market Size & Forecast, BY COMPONENT
8.4.2. Market Size & Forecast, BY APPLICATION
8.5. Canada
8.5.1. Market Size & Forecast, BY COMPONENT
8.5.2. Market Size & Forecast, BY APPLICATION
CHAPTER 9: EUROPE MARKET ANALYSIS
9.1. Introduction
9.2. Proteomics Market by Country
9.3. Europe Proteomics Market by Country, USD Million 2019-2031
9.3.1. Market Size & Forecast, BY COMPONENT
9.3.2. Market Size & Forecast, BY APPLICATION
9.4. Germany
9.4.1. Market Size & Forecast, BY COMPONENT
9.4.2. Market Size & Forecast, BY APPLICATION
9.5. France
9.5.1. Market Size & Forecast, BY COMPONENT
9.5.2. Market Size & Forecast, BY APPLICATION
9.6. U.K.
9.6.1. Market Size & Forecast, BY COMPONENT
9.6.2. Market Size & Forecast, BY APPLICATION
9.7. Italy
9.7.1. Market Size & Forecast, BY COMPONENT
9.7.2. Market Size & Forecast, BY APPLICATION
9.8. Spain
9.8.1. Market Size & Forecast, BY COMPONENT
9.8.2. Market Size & Forecast, BY APPLICATION
9.9. Benelux
9.9.1. Market Size & Forecast, BY COMPONENT
9.9.2. Market Size & Forecast, BY APPLICATION
9.10. Rest of Europe
9.10.1. Market Size & Forecast, BY COMPONENT
9.10.2. Market Size & Forecast, BY APPLICATION
CHAPTER 10: ASIA-PACIFIC MARKET ANALYSIS
10.1. Introduction
10.2. Proteomics Market by Country
10.3. Asia Pacific Proteomics Market by Country, USD Million 2019-2031
10.3.1. Market Size & Forecast, BY COMPONENT
10.3.2. Market Size & Forecast, BY APPLICATION
10.4. China
10.4.1. Market Size & Forecast, BY COMPONENT
10.4.2. Market Size & Forecast, BY APPLICATION
10.5. India
10.5.1. Market Size & Forecast, BY COMPONENT
10.5.2. Market Size & Forecast, BY APPLICATION
10.6. Japan
10.6.1. Market Size & Forecast, BY COMPONENT
10.6.2. Market Size & Forecast, BY APPLICATION
10.7. Australia
10.7.1. Market Size & Forecast, BY COMPONENT
10.7.2. Market Size & Forecast, BY APPLICATION
10.8. South Korea
10.8.1. Market Size & Forecast, BY COMPONENT
10.8.2. Market Size & Forecast, BY APPLICATION
10.9. Souethest Asia
10.9.1. Market Size & Forecast, BY COMPONENT
10.9.2. Market Size & Forecast, BY APPLICATION
10.10. Rest of Asia Pacific
10.10.1. Market Size & Forecast, BY COMPONENT
10.10.2. Market Size & Forecast, BY APPLICATION
CHAPTER 11: LATIN AMERICA AND THE CARIBBEAN MARKET ANALYSIS
11.1. Introduction
11.2. Proteomics Market by Country
11.3. Latin America Proteomics Market by Country, USD Million 2019-2031
11.3.1. Market Size & Forecast, BY COMPONENT
11.3.2. Market Size & Forecast, BY APPLICATION
11.4. Brazil
11.4.1. Market Size & Forecast, BY COMPONENT
11.4.2. Market Size & Forecast, BY APPLICATION
11.5. Mexico
11.5.1. Market Size & Forecast, BY COMPONENT
11.5.2. Market Size & Forecast, BY APPLICATION
11.6. Rest of Latin America
11.6.1. Market Size & Forecast, BY COMPONENT
11.6.2. Market Size & Forecast, BY APPLICATION
CHAPTER 12: THE MIDDLE EAST AND AFRICA MARKET ANALYSIS
12.1. Introduction
12.2. Proteomics Market by Country
12.3. MEA Proteomics Market by Country, USD Million 2019-2031
12.3.1. Market Size & Forecast, BY COMPONENT
12.3.2. Market Size & Forecast, BY APPLICATION
12.4. South Africa
12.4.1. Market Size & Forecast, BY COMPONENT
12.4.2. Market Size & Forecast, BY APPLICATION
12.5. Saudi Arabia
12.5.1. Market Size & Forecast, BY COMPONENT
12.5.2. Market Size & Forecast, BY APPLICATION
12.6. UAE
12.6.1. Market Size & Forecast, BY COMPONENT
12.6.2. Market Size & Forecast, BY APPLICATION
12.7. Rest of MEA
12.7.1. Market Size & Forecast, BY COMPONENT
12.7.2. Market Size & Forecast, BY APPLICATION
CHAPTER 13: COMPETITIVE LANDSCAPE
13.1. Introduction
13.2. Market Player Positioning, 2022
13.3. Company Evaluation Matrix
13.4. Product Mapping of Top 10 Player
13.5. Market Opportunities and Future Trends
13.6. Competitive Heatmap
13.7. Top Winning Growth Strategies
13.7.1. Major Growth Strategies
13.7.2. Expansion
13.7.3. Merger and Acquisition
13.7.4. Other Developments
CHAPTER 14: COMPANY PROFILES
14.1. AGILENT TECHNOLOGIES INC.
14.1.1. Company Overview
14.1.2. Key Executives
14.1.3. Financial Overview
14.1.4. Business COMPONENTnalysis
14.1.5. Product Portfolio
14.1.6. Key Strategic Developments
14.2. WATERS CORPORATION
14.3. BRUKER CORPORATION
14.4. MERCK KGAA
14.5. PERKIN ELMER INC.
14.6. BIO-RAD LABORATORIES INC.
14.7. LI-COR INC.
14.8. THERMO FISHER SCIENTIFIC INC.
14.9. HORIBA LTD.
14.10. DANAHER CORPORATION
14.11. OTHERS

Tables & Figures

LIST OF TABLES
Table 1. GLOBAL PROTEOMICS MARKET INDUSTRY SNAPSHOT, 2022-2031
Table 2. GLOBAL PROTEOMICS MARKET SHARE, BY COMPONENT -2019-2031 (USD MILLION)
Table 3. GLOBAL PROTEOMICS MARKET MICROARRAY, BY REGION-2019-2031 (USD MILLION)
Table 4. GLOBAL PROTEOMICS MARKET X RAY CRYSTALLOGRAPHY, BY REGION-2019-2031 (USD MILLION)
Table 5. GLOBAL PROTEOMICS MARKET SPECTROMETRY, BY REGION-2019-2031 (USD MILLION)
Table 6. GLOBAL PROTEOMICS MARKET CHROMATOGRAPHY, BY REGION-2019-2031 (USD MILLION)
Table 7. GLOBAL PROTEOMICS MARKET ELECTROPHORESIS, BY REGION-2019-2031 (USD MILLION)
Table 8. GLOBAL PROTEOMICS MARKET IMMUNOASSAY, BY REGION-2019-2031 (USD MILLION)
Table 9. GLOBAL PROTEOMICS MARKET SERVICES, BY REGION-2019-2031 (USD MILLION)
Table 10. GLOBAL PROTEOMICS MARKET SHARE, BY APPLICATION -2019-2031 (USD MILLION)
Table 11. GLOBAL PROTEOMICS MARKET DRUG DISCOVERY, BY REGION-2019-2031 (USD MILLION)
Table 12. GLOBAL PROTEOMICS MARKET DISEASE DIAGNOSIS, BY REGION-2019-2031 (USD MILLION)
Table 13. GLOBAL PROTEOMICS MARKET OTHER, BY REGION-2019-2031 (USD MILLION)
Table 14. GLOBAL PROTEOMICS MARKET SHARE, REGION -2019-2031 (USD MILLION)
Table 15. GLOBAL PROTEOMICS MARKET FOR NORTH AMERICA, BY REGION-2019-2031 (USD MILLION)
Table 16. GLOBAL PROTEOMICS MARKET FOR ASIA PACIFIC BY REGION-2019-2031 (USD MILLION)
Table 17. GLOBAL PROTEOMICS MARKET FOR EUROPE BY REGION-2019-2031 (USD MILLION)
Table 18. GLOBAL PROTEOMICS MARKET FOR MIDDLE EAST & AFRICA BY REGION-2019-2031 (USD MILLION)
Table 19. GLOBAL PROTEOMICS MARKET FOR SOUTH AMERICA BY REGION-2019-2031 (USD MILLION)
Table 20. NORTH AMERICA Proteomics Market BY COUNTRY, USD MILLION 2019-2031
Table 21. NORTH AMERICA Proteomics Market SHARE, BY COMPONENT -2019-2031 (USD MILLION)
Table 22. NORTH AMERICA Proteomics Market SHARE, BY APPLICATION -2019-2031 (USD MILLION)
Table 23. NORTH AMERICA Proteomics Market SHARE, by REGION -2019-2031 (USD MILLION)
Table 24. U.S. Proteomics Market SHARE, BY COMPONENT -2019-2031 (USD MILLION)
Table 25. U.S. Proteomics Market SHARE, BY APPLICATION -2019-2031 (USD MILLION)
Table 26. U.S. Proteomics Market SHARE, by REGION -2019-2031 (USD MILLION)
Table 27. CANADA Proteomics Market SHARE, BY COMPONENT -2019-2031 (USD MILLION)
Table 28. CANADA Proteomics Market SHARE, BY APPLICATION -2019-2031 (USD MILLION)
Table 29. EUROPE Proteomics Market BY COUNTRY, USD MILLION 2019-2031
Table 30. EUROPE Proteomics Market SHARE, BY COMPONENT -2019-2031 (USD MILLION)
Table 31. EUROPE Proteomics Market SHARE, BY APPLICATION -2019-2031 (USD MILLION)
Table 32. GERMANY Proteomics Market SHARE, BY COMPONENT -2019-2031 (USD MILLION)
Table 33. GERMANY Proteomics Market SHARE, BY APPLICATION -2019-2031 (USD MILLION)
Table 34. FRANCE Proteomics Market SHARE, BY COMPONENT -2019-2031 (USD MILLION)
Table 35. FRANCE Proteomics Market SHARE, BY APPLICATION -2019-2031 (USD MILLION)
Table 36. UK Proteomics Market SHARE, BY COMPONENT -2019-2031 (USD MILLION)
Table 37. UK Proteomics Market SHARE, BY APPLICATION -2019-2031 (USD MILLION)
Table 38. ITALY Proteomics Market SHARE, BY COMPONENT -2019-2031 (USD MILLION)
Table 39. ITALY Proteomics Market SHARE, BY APPLICATION -2019-2031 (USD MILLION)
Table 40. SPAIN Proteomics Market SHARE, BY COMPONENT -2019-2031 (USD MILLION)
Table 41. SPAIN Proteomics Market SHARE, BY APPLICATION -2019-2031 (USD MILLION)
Table 42. BENELUX Proteomics Market SHARE, BY COMPONENT -2019-2031 (USD MILLION)
Table 43. BENELUX Proteomics Market SHARE, BY APPLICATION -2019-2031 (USD MILLION)
Table 44. REST OF EUROPE Proteomics Market SHARE, BY COMPONENT -2019-2031 (USD MILLION)
Table 45. REST OF EUROPE Proteomics Market SHARE, BY APPLICATION -2019-2031 (USD MILLION)
Table 46. ASIA PACIFIC Proteomics Market BY COUNTRY, USD MILLION 2019-2031
Table 47. ASIA PACIFIC Proteomics Market SHARE, BY COMPONENT -2019-2031 (USD MILLION)
Table 48. ASIA PACIFIC Proteomics Market SHARE, BY APPLICATION -2019-2031 (USD MILLION)
Table 49. CHINA Proteomics Market SHARE, BY COMPONENT -2019-2031 (USD MILLION)
Table 50. CHINA Proteomics Market SHARE, BY APPLICATION -2019-2031 (USD MILLION)
Table 51. INDIA Proteomics Market SHARE, BY COMPONENT -2019-2031 (USD MILLION)
Table 52. INDIA Proteomics Market SHARE, BY APPLICATION -2019-2031 (USD MILLION)
Table 53. JAPAN Proteomics Market SHARE, BY COMPONENT -2019-2031 (USD MILLION)
Table 54. JAPAN Proteomics Market SHARE, BY APPLICATION -2019-2031 (USD MILLION)
Table 55. AUSTRALIA Proteomics Market SHARE, BY COMPONENT -2019-2031 (USD MILLION)
Table 56. AUSTRALIA Proteomics Market SHARE, BY APPLICATION -2019-2031 (USD MILLION)
Table 57. SOUTH KOREA Proteomics Market SHARE, BY COMPONENT -2019-2031 (USD MILLION)
Table 58. SOUTH KOREA Proteomics Market SHARE, BY APPLICATION -2019-2031 (USD MILLION)
Table 59. SOUETHEST ASIA Proteomics Market SHARE, BY COMPONENT -2019-2031 (USD MILLION)
Table 60. SOUETHEST ASIA Proteomics Market SHARE, BY APPLICATION -2019-2031 (USD MILLION)
Table 61. REST OF ASIA PACIFIC Proteomics Market SHARE, BY COMPONENT -2019-2031 (USD MILLION)
Table 62. REST OF ASIA PACIFIC Proteomics Market SHARE, BY APPLICATION -2019-2031 (USD MILLION)
Table 63. LATIN AMERICA Proteomics Market BY COUNTRY, USD MILLION 2019-2031
Table 64. LATIN AMERICA Proteomics Market SHARE, BY COMPONENT -2019-2031 (USD MILLION)
Table 65. LATIN AMERICA Proteomics Market SHARE, BY APPLICATION -2019-2031 (USD MILLION)
Table 66. BRAZIL Proteomics Market SHARE, BY COMPONENT -2019-2031 (USD MILLION)
Table 67. BRAZIL Proteomics Market SHARE, BY APPLICATION -2019-2031 (USD MILLION)
Table 68. MEXICO Proteomics Market SHARE, BY COMPONENT -2019-2031 (USD MILLION)
Table 69. MEXICO Proteomics Market SHARE, BY APPLICATION -2019-2031 (USD MILLION)
Table 70. REST OF LATIN AMERICA Proteomics Market SHARE, BY COMPONENT -2019-2031 (USD MILLION)
Table 71. REST OF LATIN AMERICA Proteomics Market SHARE, BY APPLICATION -2019-2031 (USD MILLION)
Table 72. MEA Proteomics Market BY COUNTRY, USD MILLION 2019-2031
Table 73. MEA Proteomics Market SHARE, BY COMPONENT -2019-2031 (USD MILLION)
Table 74. MEA Proteomics Market SHARE, BY APPLICATION -2019-2031 (USD MILLION)
Table 75. SOUTH AFRICA Proteomics Market SHARE, BY COMPONENT -2019-2031 (USD MILLION)
Table 76. SOUTH AFRICA Proteomics Market SHARE, BY APPLICATION -2019-2031 (USD MILLION)
Table 77. SAUDI ARABIA Proteomics Market SHARE, BY COMPONENT -2019-2031 (USD MILLION)
Table 78. SAUDI ARABIA Proteomics Market SHARE, BY APPLICATION -2019-2031 (USD MILLION)
Table 79. UAE Proteomics Market SHARE, BY COMPONENT -2019-2031 (USD MILLION)
Table 80. UAE Proteomics Market SHARE, BY APPLICATION -2019-2031 (USD MILLION)
Table 81. REST OF MEA Proteomics Market SHARE, BY COMPONENT -2019-2031 (USD MILLION)
Table 82. REST OF MEA Proteomics Market SHARE, BY APPLICATION -2019-2031 (USD MILLION)
Table 83. KEY EXPANSIONS (2019-2022)
Table 84. KEY MERGERS AND ACQUISITION (2019-2022)
Table 85. OTHER KEY DEVELOPMENTS (2019-2022)

LIST OF FIGURES
Figure 1. REGIONAL ANALYSIS (2022 & 2031)
Figure 2. RESEARCH PROCESS
Figure 3. ANALYSIS FRAMEWORK
Figure 4. IMPACT OF KEY REGULATION ON THE MARKET
Figure 5. SWOT ANALYSIS
Figure 6. GLOBAL PROTEOMICS MARKET SHARE, BY COMPONENT -2023 & 2031 (USD MILLION)
Figure 7. GLOBAL PROTEOMICS MARKET , MICROARRAY -2019-2031 (USD MILLION)
Figure 8. GLOBAL PROTEOMICS MARKET , X RAY CRYSTALLOGRAPHY -2019-2031 (USD MILLION)
Figure 9. GLOBAL PROTEOMICS MARKET , SPECTROMETRY -2019-2031 (USD MILLION)
Figure 10. GLOBAL PROTEOMICS MARKET , CHROMATOGRAPHY -2019-2031 (USD MILLION)
Figure 11. GLOBAL PROTEOMICS MARKET , ELECTROPHORESIS -2019-2031 (USD MILLION)
Figure 12. GLOBAL PROTEOMICS MARKET , IMMUNOASSAY -2019-2031 (USD MILLION)
Figure 13. GLOBAL PROTEOMICS MARKET , SERVICES -2019-2031 (USD MILLION)
Figure 14. GLOBAL PROTEOMICS MARKET SHARE, BY APPLICATION -2023 & 2031 (USD MILLION)
Figure 15. GLOBAL PROTEOMICS MARKET , DRUG DISCOVERY -2019-2031 (USD MILLION)
Figure 16. GLOBAL PROTEOMICS MARKET , DISEASE DIAGNOSIS -2019-2031 (USD MILLION)
Figure 17. GLOBAL PROTEOMICS MARKET , OTHERS -2019-2031 (USD MILLION)
Figure 18. MARKET PLAYER POSITIONING, 2022
Figure 19. COMPANY EVALUATION MATRIX
Figure 20. PRODUCT MAPPING OF TOP 10 PLAYERS
Figure 21. COMPETITIVE HEATMAP OF KEY PLAYERS

Frequently Asked Questions (FAQ):

  • Which is the leading segment in the Global Proteomics Market?

    In the proteomics market, the drug discovery segment often dominates based on application.
  • What are the key factors driving the Global Proteomics Market?

    Growing Demand for Personalized Medicine, Advancements in Technology are some of the key factors driving the growth in the market.
  • Which region will contribute notably towards the Global Proteomics Market?

    North America region to contribute the major share towards the market growth.
  • What are the key players in the Global Proteomics Market?

    Agilent Technologies Inc., Waters Corporation, Bruker Corporation, Merck KGaA, Perkin Elmer Inc, Bio-Rad Laboratories Inc, Li-Cor Inc, Thermo Fisher Scientific Inc., Horiba Ltd., Danaher Corporation and Others.

Buying Options

Original price was: $6,000.00.Current price is: $5,100.00.
Original price was: $5,000.00.Current price is: $4,500.00.
Original price was: $4,000.00.Current price is: $3,800.00.